Newbury Pharmaceuticals announced the Marketing Authorization (MA) of Desmopressin Newbury 60, 120 & 240 mcg sublingual tablets in Sweden as the first country in a Scandinavian registration procedure. Approvals in Norway and Denmark are expected to follow upon finalized national reviews. Nocturia is defined as "the complaint that the individual has to wake at night one or more times for voiding (i.e. to urinate)".

Nocturia becomes more common with age. More than 50% of men and women over the age of 60 have been measured to have nocturia in many communities. The brand sold over 10 mio in Scandinavia between June 2022 and May 2023, according to DLMI.